Errol M. Rudman’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6,090
Closed -$1.67M 18
2019
Q1
$1.67M Hold
6,090
1.13% 19
2018
Q4
$1.36M Sell
6,090
-410
-6% -$96.2K 0.95% 20
2018
Q3
$1.59M Sell
6,500
-1,000
-13% -$230K 0.59% 40
2018
Q2
$1.55M Hold
7,500
0.72% 38
2018
Q1
$1.55M Hold
7,500
0.74% 40
2017
Q4
$1.42M Hold
7,500
0.69% 37
2017
Q3
$1.42M Sell
7,500
-800
-10% -$145K 0.81% 30
2017
Q2
$1.45M Sell
8,300
-1,100
-12% -$185K 0.73% 31
2017
Q1
$1.44M Hold
9,400
0.93% 24
2016
Q4
$1.33M Hold
9,400
0.92% 20
2016
Q3
$1.5M Hold
9,400
1.21% 18
2016
Q2
$1.39M Sell
9,400
-600
-6% -$88.6K 1.33% 15
2016
Q1
$1.42M Sell
10,000
-38,050
-79% -$5.1M 0.96% 21
2015
Q4
$6.82M Sell
48,050
-23,950
-33% -$3.19M 2.58% 18
2015
Q3
$8.8M Hold
72,000
3.44% 14
2015
Q2
$9.34M Hold
72,000
3.15% 13
2015
Q1
$9.67M Hold
72,000
3.35% 10
2014
Q4
$9.02M Buy
72,000
+20,000
+38% +$2.43M 3.67% 10
2014
Q3
$6.33M Hold
52,000
3.17% 10
2014
Q2
$6.14M Hold
52,000
3.12% 11
2014
Q1
$6.25M Buy
52,000
+30,000
+136% +$3.57M 3.62% 8
2013
Q4
$2.45M Buy
+22,000
New +$2.19M 1.46% 24

Other funds holding TMO

Errol M. Rudman's TMO Position: Q2 2019 in Review

Errol M. Rudman sold out of Thermo Fisher Scientific (TMO) in Q2 2019, closing a stake of 6,090 shares — an estimated $1.67M sold.

Errol M. Rudman first reported a position in TMO in Q4 2013 and held it in 22 quarters. The position peaked at $9.67M in Q1 2015. 1,559 funds tracked by Wall St. Rank hold TMO as of Q2 2019.

  • Errol M. Rudman reported no remaining Thermo Fisher Scientific position as of Q2 2019 after selling out during the quarter.
  • Errol M. Rudman sold 6,090 Thermo Fisher Scientific shares in Q2 2019, an estimated $1.67M.
  • Errol M. Rudman first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 22 quarters.
  • Errol M. Rudman's Thermo Fisher Scientific position peaked at $9.67M in Q1 2015.
  • 1,559 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2019.

Based on Errol M. Rudman's 13F filing for Q2 2019.